Procalcitonin to distinguish viral from bacterial pneumonia: a systematic review and meta-analysis

IS Kamat, V Ramachandran, H Eswaran… - Clinical Infectious …, 2020 - academic.oup.com
Because of the diverse etiologies of community-acquired pneumonia (CAP) and the
limitations of current diagnostic modalities, serum procalcitonin levels have been proposed …

Updates on community acquired pneumonia management in the ICU

GB Nair, MS Niederman - Pharmacology & therapeutics, 2021 - Elsevier
While the world is grappling with the consequences of a global pandemic related to SARS-
CoV-2 causing severe pneumonia, available evidence points to bacterial infection with …

BTS guidelines for the management of community acquired pneumonia in adults: update 2009

WS Lim, SV Baudouin, RC George, AT Hill… - Thorax, 2009 - thorax.bmj.com
SYNOPSIS OF RECOMMENDATIONS A summary of the initial management of patients
admitted to hospital with suspected community acquired pneumonia (CAP) is presented in …

Acute phase reactants in infections: evidence-based review and a guide for clinicians

A Markanday - Open forum infectious diseases, 2015 - academic.oup.com
Acute-phase reactants such as erythrocyte sedimentation rate and C-reactive protein have
traditionally been used as markers for inflammation and as a measure of “sickness index” in …

Biomarkers and disease severity in children with community-acquired pneumonia

TA Florin, L Ambroggio, C Brokamp, Y Zhang… - …, 2020 - publications.aap.org
BACKGROUND: Host biomarkers predict disease severity in adults with community-
acquired pneumonia (CAP). We evaluated the association of the white blood cell (WBC) …

Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD

D Stolz, M Christ-Crain, NG Morgenthaler, J Leuppi… - Chest, 2007 - Elsevier
Background A novel approach to estimate the severity of COPD exacerbation and predict its
outcome is the use of biomarkers. We assessed circulating levels of copeptin, the precursor …

Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes

S Krüger, S Ewig, R Marre… - European …, 2008 - publications.ersnet.org
The aim of the present study was to investigate the prognostic value, in patients with
community-acquired pneumonia (CAP), of procalcitonin (PCT) compared with the …

Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]

M Christ-Crain, NG Morgenthaler, D Stolz, C Müller… - Critical Care, 2006 - Springer
Introduction Pro-adrenomedullin (proADM) is helpful for individual risk assessment and
outcome prediction in sepsis. A major cause of sepsis is community-acquired pneumonia …

Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia

DT Huang, LA Weissfeld, JA Kellum, DM Yealy… - Annals of emergency …, 2008 - Elsevier
STUDY OBJECTIVE: The Pneumonia Severity Index and CURB-65 predict outcomes in
community-acquired pneumonia but have limitations. Procalcitonin, a biomarker of bacterial …

Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections

B Müller, N Morgenthaler, D Stolz… - European journal of …, 2007 - Wiley Online Library
Background Vasopressin has haemodynamic as well as osmoregulatory effects, and reflects
the individual stress response. Copeptin is cosynthesized with vasopressin, directly …